Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check18 days agoChange DetectedThe Revision label on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedRevision: v3.4.2 is now displayed on the page. The previous government funding lapse notice has been removed, and core study content remains unchanged.SummaryDifference0.3%

- Check54 days agoChange DetectedA site-wide Notice about a lapse in government funding and updated operating status was added, and the page revision indicator changed from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check61 days agoChange DetectedThe changes are minor UI and metadata updates (Show glossary toggle, Last Update Submitted that Met QC Criteria wording, No FEAR Act data notice, and Revision: v3.4.0) and do not affect core study information or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.